MicroRNAs and apoptosis: Implications in the molecular therapy of human disease

Clinical and Experimental Pharmacology and Physiology

Volumn 36, Issue 10, 2009, Pages 951-960

  Yang, Bao Feng ^a   Lu, Yan Jie ^a   Wang, Zhi Guo ^a,b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b MONTREAL HEART INSTITUTE   (Canada)

Author keywords

Apotosis; Microrna; Molecular therapy

Indexed keywords

ANTI MICRORNA OLIGONUCLEOTIDE; ANTISENSE OLIGONUCLEOTIDE; CASPASE 9; EFFECTOR CASPASE; HEAD INVOLUTION DEFECTIVE PROTEIN; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 70; MESSENGER RNA; MICRORNA; MICRORNA MASKING ANTISENSE OLIGONUCLEOTIDE; NUCLEOTIDE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN MCL 1; RAS PROTEIN; SMAD3 PROTEIN; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR E2F3; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

APOPTOSIS; CANCER THERAPY; DRUG MECHANISM; DRUG TARGETING; GENE EXPRESSION; HUMAN; MOLECULAR THERAPY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN RNA BINDING; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; APOPTOSIS; DISEASE; DRUG DELIVERY SYSTEMS; GENE EXPRESSION REGULATION; GENE TARGETING; HUMANS; MICRORNAS; SIGNAL TRANSDUCTION; THERAPEUTICS;

EID: 72049096984     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2009.05245.x     Document Type: Review

References (92)

1. Baehrecke EH. miRNAs: Micro managers of programmed cell death. Curr. Biol. 2003; 13: R473-5.
2. Hwang HW, Mendell JT. MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br. J. Cancer 2006; 94: 776-780.
3. Jovanovic M, Hengartner MO. MiRNAs and apoptosis: RNAs to die for Oncogene 2006; 25: 6176-6187 (Pubitemid 44527848)
4. Nakahara K, Carthew RW. Expanding roles for miRNAs and siRNAs in cell regulation. Curr. Opin. Cell Biol 2004; 16: 127-133 (Pubitemid 38757288)
5. Xu P, Quo M, Hay BA. MicroRNAs and the regulation of cell death. Trends Genet. 2004; 20: 617-624.
6. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993; 75: 843-854 (Pubitemid 24014542)
7. Lee Y, Ahn C, Han J et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003; 425: 415-419 (Pubitemid 37187272)
8. Lee Y, Kim M, Han J et al. MicroRNA genes are transcribed by RNA polymerase II. EMBOJ. 2004; 23:4051-4060 (Pubitemid 39472426)
9. Cai X, Hagedorn. CH, Cullen BR. Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA 2004; 10: 1957-1966 (Pubitemid 39557833)
10. Inoue A, Sawata SY, Taira K. Molecular design and delivery of siRNA. J. Drug Target. 2006; 14:448-455.
11. Natt F. siRNAs in drug discovery. Target validation and beyond. Curr. Opin. Mol. Ther. 2007; 9:242-247.
12. Scherr M, Eder M. Gene silencing by small regulatory RNAs in mammalian cells. Cell Cycle 2007; 6: 444-449 (Pubitemid 46393448)
13. Lewis BP, Shih I-H, Jones-Rhoades MW, Bartel DP, Bürge CB. Prediction of mammalian microRNA targets. Cell 2003; 115: 787-798.
14. Lewis BP, Bürge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120:15-20.
15. Jackson. RJ, Standart N. How do microRNAs regulate gene expression? Sci. STKE 2007; 23:243-249.
16. Nilsen TW. Mechanisms of microRNA-mediated gene regulation in animal cells. Trends Genet. 2007; 23: 243-249 (Pubitemid 46628981)
17. Pillai RS, Bhattacharyya SN, Filipowicz W Repression of protein synthesis by miRNAs: How many mechanisms? Trends Cell Biol. 2007; 17:118-126.
18. Pillai RS, Bhattacharyya SN, Artus CG et al. Inhibition of translational initiation, by Let-7 MicroRNA in human, cells. Science 2005; 309: 1573-1576.
19. Humphreys DT, Westman. BJ, Martin DI, Preiss T. MicroRNAs control translation initiation by inhibiting eukaryotic initiation factor 4E/cap and poly (A) tail function. Proc. Natl Acad. Sci. USA 2005; 102: 16961-16966 (Pubitemid 41692666)
20. Miranda KC, Huynh T, Tay Y et al A. pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell 2006; 126: 1203-1217 (Pubitemid 44380294)
21. Ambras V. The functions of animal microRNAs. Nature 2004; 431: 350-355.
22. Alvarez-Garcia I, Miska EA. MicroRNA functions in animal development and human disease. Development 2005; 132:4653-4662 (Pubitemid 41685276)
23. Matsubara H, Takeuchi T, Nishikawa E et al. Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92. Oncogene 2007; 26: 6099-6105 (Pubitemid 47373805)
24. Chan JA, Krichevsky AM, Kosik KS. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Ret. 2005; 65: 6029-6033 (Pubitemid 40994386)
25. Corsten MF, Miranda R, Kasmieh R, Krichevsky AM, Weissleder R, Shah K. MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. Cancer Res. 2007; 67: 8994-9000. (Pubitemid 47535880)
26. Si ML, Zhu S, Wu H, Lu Z, Wu F, Mo YY. miR-21-mediated tumor growth. Oncogene 2007; 26: 2799-2803.
27. Zhu S, Si ML, Wu H, Mo YY. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPMl). J. Biol. Chem. 2007; 282: 14328-14336 (Pubitemid 47100416)
28. Gupta A, Gartner JJ, Sethupathy P, Hatzigeorgiou AG, Fraser NW. Anti-apoptotic function of a microRNA encoded by the HSV-I latencyassociated transcript. Nature 2006; 442: 82-85 (Pubitemid 44064213)
29. Cimmino A, Calin GA, Fabbri. M et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Natl Acad. Sci. USA 2005; 102:13944-13949 (Pubitemid 41377683)
30. Raver-Shapira N, Marciano E, Mein. E et al. Transcriptional activation of miR-34a contributes to p53-medi.ated apoptosis. Mol. Cell 2007; 26: 731-743 (Pubitemid 46856247)
31. Tarasov V, Jung P, Verdoodt B et al. Differential regulation of micro-RNAs by p53 revealed by massively parallel sequencing: MiR-34a is a p53 target that induces apoptosis and Gl-arrest. Cell Cycle 2007; 6: 1586-1593 (Pubitemid 47327945)
32. Tazawa H, Tsuchiya N, Izumiya M, Nakagama H. Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc. Natl Acad. Sci. USA 2007; 104: 15472-15477 (Pubitemid 47502941)
33. Chang TC, Wentzel EA, Kent OA et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol. Cell 2007; 26: 745-752.
34. Welch C, Chen Y, Stallings RL. Micro.RNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene 2007; 26: 5017-5022 (Pubitemid 47172643)
35. Bommer GT, Gerin I, Feng Y et al p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr. Biol. 2007; 17: 1298-1307 (Pubitemid 47176893)
36. Xu C, Lu Y, Lin H et al. The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis via targeting HSP60/HS.P70 and caspase-9 in cardiomyocytes. J. Cell Sci 2007; 120: 3045-3052 (Pubitemid 47517087)
37. Izumiya Y, Kim S, Izumi Y et al. Apoptosis signal-regulating kinase 1 plays a pivotal, role in angiotensin II-induced cardiac hypertrophy and remodeling. Circ. Res. 2003; 93: 874-883 (Pubitemid 37363062)
38. Tea BS, Dam TV, Moreau P, Hamet P, de Blois D. Apoptosis during regression, of cardiac hypertrophy in spontaneously hypertensive rats. Temporal regulation, and spatial heterogeneity. Hypertension 1999; 34: 229-235 (Pubitemid 29409220)
39. Teiger E, Than VD, Wisnewsky C et al. Apoptosis in pressure overload-induced heart hypertrophy in the rat. J. Clin. Invest. 1996; 97: 2891-2897 (Pubitemid 26197104)
40. Yang B, Lin H, Xiao J et al. The muscle-specific microRNA miR-1 causes cardiac arrhythmias by targeting GJAl and KCNJ2 genes. Nat. Med. 2007;13: 486-491 (Pubitemid 46559834)
41. Rodriguez M, Lucchesi BR, Schaper J. Apoptosis in myocardial infarction. Ann. Med. 2002; 34:470-479
42. Zidar N, Jera J, Maja J, Dusan S. Caspases in. myocardial infarction. Adv. Clin. Chem. 2007; 44: 1-33.
43. Han. H, Wang H, Long H, Nattel S, Wang Z. Oxidative preconditioning and apoptosis in 1-cells. Roles of protein kinase B and mitogenactivated protein kinases. J. Biol. Chem. 2001; 276: 26357-26364 (Pubitemid 37412853)
44. Han H, Long H, Wang H et al. Cellular remodeling of apoptosis in response to transient oxidative insult in. rat ventricular cell line H9c2: A critical role of the mitochondria death pathway. Am. J. Physiol. Heart Circ. Physiol. 2004; 286: H2169-82.
45. Lu Y, Zhou J, Xu C et al AKT/STAT and PI3K/AKT pathways form a mutual transactivation loop and afford lasting resistance to oxidative stress-induced apoptosis in cardiomyocytes. Cell Physiol. Biochem. 2008; 21: 305-314 (Pubitemid 351591422)
46. Cho S-G, Choi E-J. Apoptotic signaling pathways: Caspases and stressactivated protein, kinases. J. Biochem. Mol. Biol. 2002; 35: 24-27
47. Mignotte B, Vayssiere JL. Mitochondria and apoptosis. Eur. J. Biochem. 1998; 252: 1-15.
48. + channels in regulating tumor cell proliferation and apoptosis. Pflügers Arch. 2004; 448: 274-286
49. Johnson SM, Grosshans H, Shingara J et al. RAS is regulated by the let-7 microRNA family. Cell 2005; 120: 635-647 (Pubitemid 40343076)
50. Meng F, Henson. R, Wehbe-Janek H, Smith H, Ueno Y, Patel. T. The MicroRNA let-7a modulates interleukin-6-dependent STAT-3 survival signaling in malignant human cholangiocytes. J. Biol. Chem. 2007; 282: 8256-8264 (Pubitemid 47093612)
51. Ji. R, Cheng Y, Yue J et al. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of microRNA in vascular neointimal lesion formation. Circ. Res. 2007; 100: 1579-1588 (Pubitemid 46897261)
52. Asangani IA, Rasheed SA, Nikolova DA et al. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 2008; 27: 2128-2136
53. Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A, Lund AH. Programmed cell, death 4 (PDCD4) is an important functional target of the microRNA, miR-21 in breast cancer cells. J. Biol. Chem. 2007; 263:1026-1033
54. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT. c-Mycregulated microRNAs modulate E2F1 expression. Nature 2005; 435: 839-843
55. Sylvestre Y, Guire V, Querido E et al. An E2F/miR-20a autoregulatory feedback loop. J. Biol. Chem. 2007; 282: 2135-2143
56. Mott JL, Kobayashi S, Bronk SF, Gores GJ. mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene 2007; 26: 6133-6140 (Pubitemid 47414372)
57. Scott GK, Mattie MD, Berger CE, Benz SC, Benz CC. Rapid alteration of microRNA levels by histone deacetylase inhibition. Cancer Res. 2006; 66:1277-1281
58. Lin KM, Lin B, Lian IY, Mestril R, Scheffler I, Dillmann WH. Combined and individual mitochondrial HSP60 and HSPlO expression in cardiac myocytes protects mitochondrial function and prevents apoptotic cell deaths induced by simulated ischemia-reoxygenation, Circulation 2001; 103: 1787-1792 (Pubitemid 32291417)
59. Kirchhoff SR, Gupta S, Knowlton AA. Cytosolic HSP60, apoptosis, and myocardial injury. Circulation 2002; 105:2899-2904
60. Marber MS, Mestril R, Chi. SH, Sayen MR. Overexpression of the rat inducible 70 kDa heat shock, protein in a transgenic mouse increases the resistance of the heart to ischemic injury. J. Clin. Invest. 1995; 95: 1446-1456
61. Shan YX, Liu TJ, Su HF, Samsamshariat A, Mestril R, Wang PH. HsplO and Hsp60 modulate Bcl-2 family and mitochondria apoptosis signaling induced by doxorubicin in cardiac muscle cells. J. Mol. Cell. Cardiol. 2003; 35: 1135-1143 (Pubitemid 37083257)
62. Latchman DS. Heat shock proteins and cardiac protection. Cardiovasc. Res. 2001; 51: 637-646 (Pubitemid 32800706)
63. Han Y, Chen YS, Liu Z et al. Overexpression of HAX-1 protects cardiac myocytes from apoptosis through caspase-9 inhibition. Circ. Res. 2006; 99: 415-423 (Pubitemid 44253698)
64. Bialik S, Cryns VL, Drincic A et al. The mitochondrial apoptotic pathway is activated by serum and glucose deprivation in cardiac myocytes. Circ: Res. 1999; 85: 403-414 (Pubitemid 29409617)
65. Kannan K, Jain SK. Oxidative stress and apoptosis. Pathophysiology 2000;7:153-163
66. Murray MM, Mullan PB, Harkin DP. Role played by BRCAl in transcriptional regulation in response to therapy. Biochem. Soc. Trans. 2007; 35: 1342-1346
67. Zhang H, Somasundaram K, Peng Yet al. BRCA1 physically associates with p53 and stimulates its transcriptional activity. Oncogene 1998; 16:1713-1721 (Pubitemid 28175052)
68. Andrews HN, Mullan. PB, McWilliams S et al. BRCA1 regulates the interferon gamma-mediated apoptotic response. J. Biol. Chem. 2002; 277: 26225-26232 (Pubitemid 34967110)
69. Harkin DP, Bean. JM, Miklos D et al. Induction, of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCAl. Cell 1999; 97: 575-586 (Pubitemid 29256961)
70. Cui Q, Yu Z, Purisima E, Wang E. Principles of microRNA regulation of a human, cellular signaling network. Mol Systems Biol. 2006; 2:46-52.
71. Hammond SM. MicroRNA therapeutics: A new niche for antisense nucleic acids. Trends Mol. Med. 2006; 12: 99-101.
72. Krutzfeldt J, Rajewsky N, Braich R. et al. Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005; 438: 685-689
73. Xiao J, Yang B, Lin H, Lu Y, Luo X, Wang Z. Novel approaches for gene-specific interference via manipulating actions of microRNAs: Examination on the pacemaker channel genes HCN2 and HCN4. J. Cell. Physiol. 2007; 212: 285-292 (Pubitemid 47025616)
74. Accili EA, Proenza C, Baruscotti M, DiFrancesco D. From funny current to HCN channels: 20 years of excitation. News Physiol. Sci. 2002; 17: 32-37
75. Santero B, Tibbs GR. The HCN gene family: Molecular basis of the hyperpolarization-activated pacemaker channels. Ann. N Y. Acad. Sci. 1999; 868: 741-764
76. Robinson RB, Brink PR, Cohen IS, Rosen MR. If and the biological pacemaker. Pharmacol. Res. 2006; 53:407-415
77. Choi WY, Giraldez AJ, Schier AF. Target protectors reveal dampening and balancing of Nodal agonist and antagonist by miR-430. Science 2007; 318:271-274
78. DiFrancesco D. Cardiac pacemaker I(f) current and its inhibition by heart rate-reducing agents. Curr. Med. Res. Opin. 2005; 21:1115-1122
79. Naguibneva I, Ameyar-Zazoua M, Nonne N et al. An LNA-based loss-of-function assay for micro-RNAs. Biomed. Pharmacother 2006; 60: 633-638
80. Ørom UA, Kauppinen S, Lund AH. LNA-modified oligonucleotides mediate specific inhibition of microRNA function. Gene 2006; 372: 137-141
81. Obernosterer G, Martinez J, Alenius M. Locked nucleic acid-based in situ detection of microRNAs in mouse tissue sections. Nat. Protoc. 2007; 2: 1508-1514 (Pubitemid 46952329)
82. Griffiths-Jones S. The microRNA registry. Nucleic Acids Res. 2004; 32 (Database issue): D109-11.
83. John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS. Human MicroRNA targets. PLoS Biol. 2004; 2: e363.
84. Rusinov V, Baev V, Minkov IN, Tabler M. Microlnspector: A web tool for detection of miRNA binding sites in an RNA sequence. Nucleic Acids Res. 2005; 33 (Webserver issue): W696-700.
85. Hsu PW, Huang HD, Hsu SD et al. miRNAMap: Genomic maps of microRNA genes and their target genes in mammalian genomes. Nucleic Acids Res. 2006; 34 (Database issue): D135-9.
86. Rehmsmeier M, Steffen P, Höchsmann M, Giegerich R. Fast and effective prediction, of microRNA/target duplexes. RNA 2004; 10: 1507-1517 (Pubitemid 39288185)
87. Nam J, Kim JH, Kim SK, Zhang B-T. ProMiRII, a web server for clustered, nonclustered, conserved, nonconserved miRNA prediction. Nucleic Acids Res. 2006; 34 (Webserver issue): W455-8.
88. Sethupathy P, Corda B, Hatziegeorgiou AG. TarBase: A comprehensive database of experimentally supported animal microRNA targets. RNA 2006; 12:192-197 (Pubitemid 43121923).
89. Brennecke J, Stark A, Russell RB, Cohen SM. Principles of microRNA-target recognition. PLoS Biol. 2005; 3:404-18.
90. Stark A, Brennecke J, Russell RB, Cohen SM. Identification of Drosophila MicroRNA targets. PLoS Biol. 2003; 1: e60.
91. Wang X, El Naqa IM. Prediction of both conserved and nonconserved microRNA targets in animals. Bioinformatics 2008; 24: 325-332 (Pubitemid 351189007)
92. Kim S-K, Nam J-W, Rhee J-K, Lee W-J, Zhang B-T. miTarget: MicroRNA target-gene prediction using a support vector machine. BMC Bioinformatics 2006; 7:411.